Differentiated thyroid cancer belongs to the small group of human malignancies with very
good prognosis. Excellent outcomes result from the unique tumour biology and constantly …

Management of thyroid carcinoma relies upon the tumour cells maintaining the differentiated
functions that are typical of normal thyroid follicular cells, such as: dependence upon …

Thyroid carcinoma comprises a spectrum of malignancies ranging from rarely lethal, slow-
growing neoplasms to among the most deadly aggressive cancers to afflict humanity …

Three years ago continental guidelines were published referring management and follow-up
of low risk thyroid cancer patients. The aim of this paper is to summarize the changes and …

The incidence of well-differentiated thyroid cancer has seen a worldwide increase in the last
three decades, although whether this is due to a 'true increase'in incidence or simply …

Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has
increased over the last few decades. It derives from follicular thyroid cells. Generally …

The clinical presentation of differentiated thyroid cancer (DTC) has changed considerably
over the last two decades. This is mainly due to improvements in our capabilities to make an …

This is the second review article on thyroid cancer dealing with the common differentiated
types that comprise 90% of thyroid cancers. Despite clinical management guidelines offered …

Furio Pacini is a Professor of Endocrinology and Chairman of the Section of Endocrinology
and Metabolism at the University of Siena. He has been involved in both clinical practice …

Well differentiated epithelial cell thyroid cancer is not classified amongst the most
aggressive diseases. Notwithstanding, it can potentially both impair quality of life and affect …